ProCE Banner Activity

Improving Diagnosis, Treatment, and QoL for MF-CTCL

Multimedia
Professor Julia Scarisbrick provides an expert perspective on improving diagnosis, treatment, and quality of life for patients with MF-CTCL in this on-demand Webcast recorded at the EORTC 2020 Cutaneous Lymphoma Task Force Virtual Meeting.

Released: February 10, 2021

Expiration: February 09, 2022

No longer available for credit.

Share

Faculty

Prof Julia Scarisbrick

Prof Julia Scarisbrick

Consultant Dermatologist
University Hospital Birmingham
Birmingham, United Kingdom

Supporters

Supported by an educational grant from

Helsinn Healthcare SA

Faculty Disclosure

Primary Author

Prof Julia Scarisbrick,

Consultant Dermatologist
University Hospital Birmingham
Birmingham, United Kingdom

Professor Julia Scarisbrick has disclosed that she has received consulting fees from Kyowa Kirin, Mallinckrodt, Recordati, and Takeda.

Staff Disclosure

Staff

Petra Cravens, PhD

Editorial Contributor

Petra Cravens, PhD, has no relevant conflicts of interest to report.

Katie Eustace, MBA

Senior Director, Global Medical Education, Europe

Katie Eustace, MBA, has no relevant conflicts of interest to report.

Kevin Obholz, PhD

Editorial Director, Hematology/Oncology

Kevin Obholz, PhD, has no relevant conflicts of interest to report.

Timothy A. Quill, PhD

Senior Managing Editor

Timothy A. Quill, PhD, has no relevant conflicts of interest to report.

Justine Stanley, MSc

Editorial Contributor

Justine Stanley, MSc, has no relevant conflicts of interest to report.